HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting of cathepsin S reduces cystic fibrosis-like lung disease.

Abstract
Cathepsin S (CatS) is upregulated in the lungs of patients with cystic fibrosis (CF). However, its role in CF lung disease pathogenesis remains unclear.In this study, β-epithelial Na+ channel-overexpressing transgenic (βENaC-Tg) mice, a model of CF-like lung disease, were crossed with CatS null (CatS-/-) mice or treated with the CatS inhibitor VBY-999.Levels of active CatS were elevated in the lungs of βENaC-Tg mice compared with wild-type (WT) littermates. CatS-/-βENaC-Tg mice exhibited decreased pulmonary inflammation, mucus obstruction and structural lung damage compared with βENaC-Tg mice. Pharmacological inhibition of CatS resulted in a significant decrease in pulmonary inflammation, lung damage and mucus plugging in the lungs of βENaC-Tg mice. In addition, instillation of CatS into the lungs of WT mice resulted in inflammation, lung remodelling and upregulation of mucin expression. Inhibition of the CatS target, protease-activated receptor 2 (PAR2), in βENaC-Tg mice resulted in a reduction in airway inflammation and mucin expression, indicating a role for this receptor in CatS-induced lung pathology.Our data indicate an important role for CatS in the pathogenesis of CF-like lung disease mediated in part by PAR2 and highlight CatS as a therapeutic target.
AuthorsDonna M Small, Ryan R Brown, Declan F Doherty, Anthony Abladey, Zhe Zhou-Suckow, Rebecca J Delaney, Lauren Kerrigan, Caoifa M Dougan, Keren S Borensztajn, Leslie Holsinger, Robert Booth, Christopher J Scott, Guillermo López-Campos, J Stuart Elborn, Marcus A Mall, Sinéad Weldon, Clifford C Taggart
JournalThe European respiratory journal (Eur Respir J) Vol. 53 Issue 3 (03 2019) ISSN: 1399-3003 [Electronic] England
PMID30655278 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright ©ERS 2019.
Chemical References
  • Epithelial Sodium Channels
  • F2rl1 protein, mouse
  • Receptor, PAR-2
  • Cathepsins
  • cathepsin S
Topics
  • Airway Obstruction (metabolism)
  • Animals
  • Cathepsins (genetics, metabolism)
  • Cystic Fibrosis (metabolism)
  • Disease Models, Animal
  • Epithelial Sodium Channels (genetics)
  • Lung (pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mucus (metabolism)
  • Pneumonia (etiology, metabolism)
  • Receptor, PAR-2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: